Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Open-Label Study to Evaluate the Effects of Natalizumab Treatment on Fatigue and Cognition in Subjects With Relapsing Forms of MS

NCT00464074 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT00464074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00464074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Open-Label Study to Evaluate the Effects of Natalizumab Treatment on Fatigue and Cognition in Subjects With Relapsing Forms of MS
Lead sponsor
Biogen
Phase
Observational
Overall status
Completed
Start date
August 1, 2007
Completion date
July 31, 2010
Enrollment
89 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis